Xintela AB (OSTO:XINT) Accumulated Depreciation : kr0.00 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Xintela AB Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Xintela AB's quarterly accumulated depreciation increased from Sep. 2023 (kr0.00 Mil) to Dec. 2023 (kr-16.49 Mil) but then stayed the same from Dec. 2023 (kr-16.49 Mil) to Mar. 2024 (kr0.00 Mil).

Xintela AB's annual accumulated depreciation increased from Dec. 2021 (kr-9.82 Mil) to Dec. 2022 (kr-13.16 Mil) and increased from Dec. 2022 (kr-13.16 Mil) to Dec. 2023 (kr-16.49 Mil).

Xintela AB Accumulated Depreciation Historical Data

The historical data trend for Xintela AB's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xintela AB Accumulated Depreciation Chart

Xintela AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-3.62

-6.64

-9.82

-13.16

-16.49

Xintela AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial															-	-	-	-16.49	-

Xintela AB Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Xintela AB Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Xintela AB's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Xintela AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xintela AB (OSTO:XINT) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

1XT:Germany

Address

Medicon Village, Lund, SWE, 22381

Website

http://www.xintela.se

Xintela AB is a biomedical company which utilises its proprietary marker technology XINMARK to develop stem cell-based therapies (XSTEM) for osteoarthritis and antibody-based therapies for Glioblastoma and Tripple-negative breast cancer. XSTEM is also evaluated for the treatment of the severe and deadly lung complication ARDS, which may affect covid-19 patients.

Xintela AB Headlines

No Headlines